Xofigo 1100 kBq/mL (30 microcurie/mL) with a total radioactivity of 6,600 kBq/vial (178 microcurie/vial) Images
Generic Name: radium 223 dichloride
This medication has been identified as Xofigo 1100 kBq/mL (30 microcurie/mL) with a total radioactivity of 6,600 kBq/vial (178 microcurie/vial). It is supplied by Bayer HealthCare Pharmaceuticals Inc.
Xofigo is used in the treatment of Prostate Cancer and belongs to the drug class therapeutic radiopharmaceuticals. Not for use in pregnancy. Xofigo 1100 kBq/mL (30 microcurie/mL) with a total radioactivity of 6,600 kBq/vial (178 microcurie/vial) is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Xofigo
- Generic Name
- radium 223 dichloride
- Strength
- 1100 kBq/mL (30 microcurie/mL) with a total radioactivity of 6,600 kBq/vial (178 microcurie/vial)
- Availability
- Prescription only
- Drug Class
- Therapeutic radiopharmaceuticals
- Pregnancy Category
- X - Not for use in pregnancy
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bayer HealthCare Pharmaceuticals Inc.
- National Drug Code (NDC)
- 50419-0208
See also:
More about Xofigo (radium 223 dichloride)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: therapeutic radiopharmaceuticals
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.